KRYSTAL BIOTECH
Krystal Biotech is a biopharmaceutical company using gene therapy to develop best in class treatments that provide significant clinical benefit for patients suffering from rare debilitating disorders.
KRYSTAL BIOTECH
Industry:
Biopharma Biotechnology Health Care
Founded:
2015-01-01
Address:
Pittsburgh, Pennsylvania, United States
Country:
United States
Website Url:
http://www.krystalbio.com
Total Employee:
11+
Status:
Active
Contact:
+1 412-586-5830
Email Addresses:
[email protected]
Total Funding:
386 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon WordPress Content Delivery Network Google Universal Analytics
Similar Organizations
21st.BIO
21st Bio has the potential to replace and improve a wide range of meals and materials with appealing sustainable bio-based alternatives.
Arcellx
Arcellx is a clinical-stage biotechnology company that provides patients with immune cell therapies.
Cache
Cache is advancing personalized medicine and digital data storage by making storage and access to biomolecules widely accessible.
Emmaus Medical
Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.
Transcend
Transcend is committed to providing safe, reliable and high quality therapy systems to treat obstructive sleep apnea.
StabiLux Biosciences
StabiLux Biosciences produces high-brightness fluorophores for biomedical researchers.
Valkyrie GRP
Valkyrie GRP is a growth-oriented investment firm that focuses on team development, early distribution, and solid, value-added partnerships.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Frazier Healthcare Partners
Frazier Healthcare Partners investment in Post-IPO Equity - Krystal Biotech
Sun Pharma
Sun Pharma investment in Funding Round - Krystal Biotech
Key Employee Changes
| Date | New article |
|---|---|
| 2022-01-18 | Krystal Biotech Appoints Jing Marantz, MD, PhD, MBA as Chief Business Officer and Rand Sutherland, MD, MPH to its Board of Directors |
Official Site Inspections
http://www.krystalbio.com Semrush global rank: 2.12 M Semrush visits lastest month: 9.6 K
- Host name: 141.193.213.21
- IP address: 141.193.213.21
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Krystal Biotech"
Company - Krystal Biotech, Inc
Krystal Biotech is focused on the underlying genetic causes of these conditions and developing targeted therapies to provide long-term benefits for patients by pioneering the development of redosable gene therapies targeting diseases …See details»
Krystal Biotech - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number +1 412-586-5830 Krystal Biotech is a biopharmaceutical company using gene therapy to develop best in class treatments that …See details»
Krystal Biotech Company Profile | Management and Employees …
SQL International Organization for Standardization . CSS World Wide Web Consortium . PHP PHP . Web Analytics (4 Technologies) Google Global Site Tag Google . ...See details»
Leadership - Krystal Biotech, Inc
Laurent Goux SVP & General Manager Europe. Laurent Goux is SVP and General Manager Europe, leading the Krystal Team in that region. Prior to joining Krystal, Laurent worked for …See details»
Krystal Biotech - Overview, News & Similar companies - ZoomInfo
Jun 5, 2024 Krystal Biotech contact info: Phone number: (412) 586-5830 Website: www.krystalbio.com What does Krystal Biotech do? Krystal Biotech, Inc. (NASDAQ:KRYS) is …See details»
Working At Krystal Biotech: Company Overview and Culture - Zippia
Mar 14, 2024 www.krystalbio.com. Organization Type. Public. CEO. Krish S. Krishnan. Social Media. Krystal Biotech is a biopharmaceutical company using gene therapy to develop best in …See details»
Krystal Biotech - Craft
Oct 29, 2024 Krystal Biotech has 3 employees across 2 locations and $50.7 m in annual revenue in FY 2023. See insights on Krystal Biotech including office locations, competitors, …See details»
Investor FAQs - Krystal Biotech, Inc.
Krystal Biotech, Inc. 2100 Wharton Street, # 701 Pittsburgh, PA 15203-1973 U.S. Mailing Address Krystal Biotech, Inc. 2100 Wharton Street, # 701 Pittsburgh, PA 15203-1973See details»
Krystal Biotech Appoints Catherine Mazzacco to Board of Directors
PITTSBURGH, March 06, 2023 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS) a biotechnology company focused on developing and commercializing …See details»
Krystal Biotech - Work in biotech
Krystal Biotech is developing gene therapies to address skin diseases. Many debilitating skin diseases lack effective treatments. Krystal is solving this by introducing therapeutic genes into …See details»
Patient Resources - Krystal Biotech, Inc
At Krystal, we believe it is a priority to lead with a ‘patients first’ mission. We strive to build enduring and supportive relationships within the patient community, and are committed to …See details»
Krystal Biotech to Present at Upcoming Investor Conferences
PITTSBURGH, Nov. 27, 2024 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS), a commercial-stage biotechnology company, today announced that Krish …See details»
Science - Krystal Biotech, Inc
Krystal Biotech has developed a differentiated vector platform focused on a number of indication areas including dermatology, respiratory, oncology, ophthalmology and aesthetics.See details»
Krystal Biotech Appoints Laurent Goux as General Manager of …
PITTSBURGH, Sept. 15, 2021 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc., (“Krystal”) (NASDAQ: KRYS), the leader in redosable gene therapies for rare diseases, today announced …See details»
Medical Professionals - Krystal Biotech, Inc
For KB707, the U.S. FDA has granted Fast Track Designation: · To delay disease progression in the treatment of patients with anti-PD-1 relapsed/refractory locally advanced or metastatic …See details»
Krystal Biotech to Present at Guggenheim 6th Annual …
PITTSBURGH, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS), a commercial-stage biotechnology company, today announced that the …See details»
Therapeutic Areas - Krystal Biotech, Inc
Autosomal Recessive Congenital Ichthyosis (ARCI) is a lifelong, severe genetic skin disease. The most common cause of ARCI is an inactivating mutation in the TGM1 gene encoding the …See details»
Krystal Biotech Reports Second Quarter 2021 Financial Results and ...
Aug 9, 2021 Not only has the Krystal team continued to advance three clinical stage programs including the pivotal GEM-3 trial, we have also grown the commercial side of our organization …See details»
Krystal Biotech Reports First Quarter 2021 Financial Results and ...
May 10, 2021 Completed enrollment in pivotal GEM-3 study of B-VEC in dystrophic epidermolysis bullosa (DEB) Strong balance sheet with March 31, 2021 cash, cash …See details»